Authors
|
Year
|
No. of patients
|
Treatment
|
MRI timing
|
Endopoint
|
Summary of results
|
---|
Koh [23]
|
2008
|
79
|
No
|
Pre surgery
|
Nodal disease
|
Sv: 0.56 (0.79–0.96) Sp: 0.81 (0.69–0.90)
|
Liu [27]
|
2016
|
183
|
No
|
Pre surgery
|
Nodal disease
|
OR: 4.22 (1.79–9.95)
|
Bugg [66]
|
2014
|
202
|
No data
|
Pre surgery
|
Metachronous metastasis
|
RR: 3.70 (95%CI: NA)
|
Sohn [24]
|
2015
|
447
|
nCRT (9.2%: 41/447)
|
Pre nCRT
|
Synchronous metastasis
|
OR:3.02 (1.65–5.51)
|
- nCRT, neoadjuvant chemoradiation therapy; R, odds ratio; RR, relative risk; Sp, specificity; Sv, sensitivity